SEC Form 4 · accession 0001534424-18-000209
ClearPoint Neuro, Inc. · CLPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy T. Richards
Director
Period of report
Jun 8, 2018
Accepted (ET)
Jun 11, 2018 · 8:53 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001285550
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | $2.18 | Jun 8, 2018 | A | 15,000 | A | — | Jun 8, 2028 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2019 annual meeting of stockholders.